Rate My Professor Charlotte Oyston

Oyston's research specializations are diabetes in pregnancy, perinatal mortality, preeclampsia, and fetal growth restriction. She serves as principal investigator for projects including the Continuous Glucose Monitoring study for pregnant people with type 2 diabetes and the Baby heAd Elevation Device (BEAD) feasibility study. She contributes to multi-centre trials such as C*STEROID, evaluating corticosteroids for threatened preterm birth, and Mi-labourTrial, assessing mifepristone for vaginal birth after caesarean. With 44 publications and 469 citations on ResearchGate, her key works include 'Therapeutic strategies for the prevention and treatment of pre-eclampsia and fetal growth restriction' (2020, Progress in Obstetrics and Gynaecology), 'Pregnancy outcomes in women with booking HbA1c ≤ 40 mmol/mol: An observational study' (2021, Australian and New Zealand Journal of Obstetrics and Gynaecology), 'Factors associated with postpartum contraceptive planning and uptake at Middlemore Hospital: A quality improvement project' (2023, Contraception), 'Telehealth and Technology for Diabetes in Pregnancy Clinics: A Quality Improvement Initiative' (2024, International Journal of Telemedicine and Applications), 'Mifepristone versus placebo to increase the rate of successful vaginal birth after caesarean section: protocol for a double-blind randomised controlled trial (Mi-labourTrial)' (2025), and 'The Tubo-ovarian abscess study (TOAST): A single-center experience' (2025, International Journal of Gynaecology and Obstetrics). Accredited as a PhD/doctoral supervisor, she engages in teaching and student supervision in obstetrics and gynaecology. Her contributions enhance clinical management and outcomes in high-risk pregnancies through evidence-based research and quality initiatives.